Advanced Proteome Therapeutics Stock Market Value
APTCF Stock | USD 0.0002 0.00 0.00% |
Symbol | Advanced |
Advanced Proteome 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Advanced Proteome's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Advanced Proteome.
10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Advanced Proteome on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Advanced Proteome Therapeutics or generate 0.0% return on investment in Advanced Proteome over 30 days. Advanced Proteome is related to or competes with WPP PLC, Marchex, Global E, Merit Medical, 51Talk Online, and Alvotech. Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a b... More
Advanced Proteome Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Advanced Proteome's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Advanced Proteome Therapeutics upside and downside potential and time the market with a certain degree of confidence.
Advanced Proteome Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Advanced Proteome's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Advanced Proteome's standard deviation. In reality, there are many statistical measures that can use Advanced Proteome historical prices to predict the future Advanced Proteome's volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Advanced Proteome's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Advanced Proteome Backtested Returns
We have found three technical indicators for Advanced Proteome Therapeutics, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Advanced Proteome are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Advanced Proteome Therapeutics has no correlation between past and present. Overlapping area represents the amount of predictability between Advanced Proteome time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Advanced Proteome price movement. The serial correlation of 0.0 indicates that just 0.0% of current Advanced Proteome price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.0 | |
Spearman Rank Test | 1.0 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
Advanced Proteome lagged returns against current returns
Autocorrelation, which is Advanced Proteome pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Advanced Proteome's pink sheet expected returns. We can calculate the autocorrelation of Advanced Proteome returns to help us make a trade decision. For example, suppose you find that Advanced Proteome has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Advanced Proteome regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Advanced Proteome pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Advanced Proteome pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Advanced Proteome pink sheet over time.
Current vs Lagged Prices |
Timeline |
Advanced Proteome Lagged Returns
When evaluating Advanced Proteome's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Advanced Proteome pink sheet have on its future price. Advanced Proteome autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Advanced Proteome autocorrelation shows the relationship between Advanced Proteome pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Advanced Proteome Therapeutics.
Regressed Prices |
Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Advanced Pink Sheet
Advanced Proteome financial ratios help investors to determine whether Advanced Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Advanced with respect to the benefits of owning Advanced Proteome security.